NCT04430699 2026-03-19
Cisplatin+Pembrolizumab+RT in Vulvar Cancer
Massachusetts General Hospital
Phase 2 Active not recruiting
Massachusetts General Hospital
M.D. Anderson Cancer Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Institute of Oncology Ljubljana
University Medical Center Groningen